Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: A planetary collision afterglow and transit of the resultant debris cloud.
Kenworthy M, Lock S, Kennedy G, van Capelleveen R, Mamajek E, Carone L, Hambsch FJ, Masiero J, Mainzer A, Kirkpatrick JD, Gomez E, Leinhardt Z, Dou J, Tanna P, Sainio A, Barker H, Charbonnel S, Garde O, Le Dû P, Mulato L, Petit T, Rizzo Smith M. Kenworthy M, et al. Among authors: barker h. Nature. 2024 Jan;625(7993):E1. doi: 10.1038/s41586-023-06874-z. Nature. 2024. PMID: 38040870 No abstract available.
A planetary collision afterglow and transit of the resultant debris cloud.
Kenworthy M, Lock S, Kennedy G, van Capelleveen R, Mamajek E, Carone L, Hambsch FJ, Masiero J, Mainzer A, Kirkpatrick JD, Gomez E, Leinhardt Z, Dou J, Tanna P, Sainio A, Barker H, Charbonnel S, Garde O, Le Dû P, Mulato L, Petit T, Rizzo Smith M. Kenworthy M, et al. Among authors: barker h. Nature. 2023 Oct;622(7982):251-254. doi: 10.1038/s41586-023-06573-9. Epub 2023 Oct 11. Nature. 2023. PMID: 37821589
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq.
Brown DV, Anttila CJA, Ling L, Grave P, Baldwin TM, Munnings R, Farchione AJ, Bryant VL, Dunstone A, Biben C, Taoudi S, Weber TS, Naik SH, Hadla A, Barker HE, Vandenberg CJ, Dall G, Scott CL, Moore Z, Whittle JR, Freytag S, Best SA, Papenfuss AT, Olechnowicz SWZ, MacRaild SE, Wilcox S, Hickey PF, Amann-Zalcenstein D, Bowden R. Brown DV, et al. Among authors: barker he. Genomics. 2024 Mar;116(2):110793. doi: 10.1016/j.ygeno.2024.110793. Epub 2024 Jan 14. Genomics. 2024. PMID: 38220132 Free article.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
Author Correction: Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function.
Maldonado H, Savage BD, Barker HR, May U, Vähätupa M, Badiani RK, Wolanska KI, Turner CMJ, Pemmari T, Ketomäki T, Prince S, Humphries MJ, Ruoslahti E, Morgan MR, Järvinen TAH. Maldonado H, et al. Among authors: barker hr. Nat Commun. 2024 Jan 3;15(1):234. doi: 10.1038/s41467-023-44574-4. Nat Commun. 2024. PMID: 38172142 Free PMC article. No abstract available.
509 results